Bicara Therapeutics raises $172.5 million in oversubscribed stock offering Feb 26, 2026 04:01PM
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Feb 26, 2026 04:01PM
Bicara Therapeutics prices $150 million stock offering at $16 per share Feb 24, 2026 11:13PM
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants Feb 24, 2026 11:13PM
Bicara Therapeutics launches $150 million public stock offering Feb 24, 2026 04:01PM


Feb 24, 2026 04:01PM Bicara Therapeutics Announces Proposed Public Offering of Common Stock
Feb 23, 2026 08:30AM Bicara Therapeutics to Participate in Upcoming Investor Conferences
Sep 30, 2025 08:42AM TD Cowen: 'Bicara Therapeutics Inc (BCAX) Remains An Attractive Investment'
May 19, 2025 09:18AM TD Cowen: 'Risk/Reward for Bicara Therapeutics Inc (BCAX) into ASCO is Great'
Feb 24, 2025 04:01PM Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Oct 8, 2024 05:29AM TD Cowen Starts Bicara Therapeutics Inc (BCAX) at Buy
Sep 16, 2024 04:01PM Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 12, 2024 09:15PM Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
Sep 3, 2024 07:29AM Bicara Therapeutics (BCAX) Files for Proposed IPO